Rock Springs Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.5M | Hold |
|
|||||
|
2025
Q2 | $19.7M | Sell |
|
|||||
|
2025
Q1 | $21.7M | Sell |
|
|||||
|
2024
Q4 | $41.6M | Sell |
|
|||||
|
2024
Q3 | $49.7M | Sell |
|
|||||
|
2024
Q2 | $34.7M | Sell |
|
|||||
|
2024
Q1 | $61.2M | Hold |
|
|||||
|
2023
Q4 | $38.8M | Buy |
|
|||||
|
2023
Q3 | $20.9M | Buy |
|
|||||
|
2023
Q2 | $34.2M | Buy |
|
|||||
|
2023
Q1 | $36.4M | Buy |
|
|||||
|
2022
Q4 | $30.6M | Buy |
|
|||||
|
2022
Q3 | $22.8M | Buy |
|
|||||
|
2022
Q2 | $15.3M | Buy |
|
|||||
|
2022
Q1 | $32M | Buy |
|
|||||
|
2021
Q4 | $47.1M | Buy |
|
|||||
|
2021
Q3 | $43.1M | Buy |
|
|||||
|
2021
Q2 | $30.4M | Buy |
|
|||||
|
2021
Q1 | $24.2M | Sell |
|
|||||
|
2020
Q4 | $44.3M | Buy |
|
|||||
|
2020
Q3 | $22.9M | Buy |
|